Filing Details
- Accession Number:
- 0001209191-22-060487
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 16:17:55
- Reporting Period:
- 2022-11-28
- Accepted Time:
- 2022-12-09 16:17:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1877741 | Ghazi Kashmolah | 1412 62Nd Street Emeryville CA 94608 | Ex Vp & Chief Quality Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-11-28 | 7,537 | $0.42 | 139,103 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |